About International Journal of Farmacia
International Journal of Farmacia (IJF) is a quarterly, peer-reviewed, open-access journal for research across the pharmaceutical sciences, pharmacy practice and their responsible application to health.
Publisher: Futuristic Publications | Online ISSN 2455-8109Publication modelQuarterly and online
AccessImmediate open access
Peer reviewOpen-identity expert review
Current licenceCC BY 4.0 from September 2026
Our mission
IJF exists to communicate sound, useful and reproducible pharmaceutical research. The journal connects laboratory discovery, formulation and manufacturing science, medicine-use evidence, clinical pharmacy, regulation and public-health practice. Priority is given to work that states a clear pharmaceutical question, uses an appropriate design, reports methods transparently and interprets findings without exaggeration.
Who the journal serves
The journal welcomes contributions from pharmacy teachers and students, academic and industrial researchers, clinical and hospital pharmacists, community pharmacists, pharmacologists, medicinal chemists, regulatory professionals, health-services researchers and other specialists whose work has a direct pharmaceutical or medicines-related contribution.
Scope test
A manuscript should explain how its findings advance pharmaceutical knowledge, medicine development, quality, safety, effectiveness, access or responsible use. General biological, chemical, agricultural or clinical work without a clear pharmaceutical connection is outside scope.
Editorial values
Scientific relevance
Decisions consider methodological soundness, originality, transparency and value to pharmacy—not the prestige, location or seniority of the authors.
Editorial independence
Fees, advertising, sponsorship and publisher interests do not determine editorial decisions. Editors and reviewers must disclose relevant conflicts.
Research integrity
IJF expects accurate authorship, ethical approval where required, responsible image and data handling, and complete disclosure of funding and competing interests.
Useful openness
Articles are freely available; under the current prospective policy, authors retain copyright and license new work under CC BY 4.0. Responsible data and protocol sharing is encouraged.
